What Appaloosa LP changed, 2016 to 2026
42 quarterly 13F filings, from Q1 2016 to Q2 2026, each read from the filing itself. A quarter is compared only with the quarter before it, so a quarter with no filing is a gap in the record, not a sale.
Reported book
$7.7bn
$5.7bn at Q1 2016
Positions
27
49 at Q1 2016
Top ten weight
79%
59% at Q1 2016
Typical quarterly turnover
about 15%
Estimated from share changes
- Q1 2016: $5.7bn
- Q2 2016: $3.8bn
- Q3 2016: $4.4bn
- Q4 2016: $5.6bn
- Q1 2017: $6.1bn
- Q2 2017: $6.7bn
- Q3 2017: $7.1bn
- Q4 2017: $10.7bn
- Q1 2018: $9.7bn
- Q2 2018: $8.8bn
- Q3 2018: $5.7bn
- Q4 2018: $2.0bn
- Q1 2019: $3.5bn
- Q2 2019: $9.3bn
- Q3 2019: $3.4bn
- Q4 2019: $4.0bn
- Q1 2020: $3.3bn
- Q2 2020: $5.8bn
- Q3 2020: $5.7bn
- Q4 2020: $6.7bn
- Q1 2021: $7.0bn
- Q2 2021: $4.8bn
- Q3 2021: $4.2bn
- Q4 2021: $3.9bn
- Q1 2022: $2.5bn
- Q2 2022: $1.6bn
- Q3 2022: $1.4bn
- Q4 2022: $1.3bn
- Q1 2023: $1.9bn
- Q2 2023: $5.4bn
- Q3 2023: $5.1bn
- Q4 2023: $5.8bn
- Q1 2024: $6.8bn
- Q2 2024: $6.2bn
- Q3 2024: $6.7bn
- Q4 2024: $6.5bn
- Q1 2025: $8.4bn
- Q2 2025: $6.4bn
- Q3 2025: $7.4bn
- Q4 2025: $6.9bn
- Q1 2026: $5.9bn
- Q2 2026: $7.7bn
- Q1 2016: 59%
- Q2 2016: 67%
- Q3 2016: 64%
- Q4 2016: 58%
- Q1 2017: 56%
- Q2 2017: 57%
- Q3 2017: 57%
- Q4 2017: 65%
- Q1 2018: 65%
- Q2 2018: 67%
- Q3 2018: 70%
- Q4 2018: 80%
- Q1 2019: 86%
- Q2 2019: 94%
- Q3 2019: 84%
- Q4 2019: 87%
- Q1 2020: 81%
- Q2 2020: 73%
- Q3 2020: 77%
- Q4 2020: 66%
- Q1 2021: 57%
- Q2 2021: 57%
- Q3 2021: 53%
- Q4 2021: 58%
- Q1 2022: 71%
- Q2 2022: 76%
- Q3 2022: 86%
- Q4 2022: 81%
- Q1 2023: 74%
- Q2 2023: 63%
- Q3 2023: 72%
- Q4 2023: 69%
- Q1 2024: 65%
- Q2 2024: 64%
- Q3 2024: 65%
- Q4 2024: 67%
- Q1 2025: 77%
- Q2 2025: 65%
- Q3 2025: 58%
- Q4 2025: 59%
- Q1 2026: 74%
- Q2 2026: 79%
The positions that defined it
Every position that was ever among the 25 largest: when it first appeared, when it was largest, and where it stands in Q2 2026. The line is its reported value each quarter.
| Position | Value over time | First listed | Largest | Q2 2026 |
|---|---|---|---|---|
| Amazon Com Inc(AMZN) | Q1 2019 | $1.2bnQ2 2026 | $1.2bn | |
| Micron Technology Inc(MU) | Q4 2016 | $2.1bnQ2 2018 | $1.1bn | |
| Taiwan Semiconductor MFG LTD(TSM)Sponsored ADS | Q2 2023 | $788mQ2 2026 | $788m | |
| Alphabet Inc(GOOG)Capital Stock Class C | Q1 2016 | $654mQ2 2026 | $654m | |
| Uber Technologies Inc(UBER) | Q2 2021 | $555mQ2 2026 | $555m | |
| iShares MSCI South Korea ETF(EWY) | Q4 2020 | $490mQ2 2026 | $490m | |
| Facebook Inc(META)Class A | Q1 2016 | $992mQ1 2018 | $380m | |
| Vistra Energy Corp(VST) | Q4 2017 | $372mQ4 2024 | $351m | |
| Nvidia Corp(NVDA) | Q1 2018 | $446mQ3 2023 | $305m | |
| NRG Energy Inc(NRG) | Q2 2017 | $318mQ2 2025 | $257m | |
| Apple Inc(AAPL) | Q1 2025 | $278mQ1 2025 | $242m | |
| Alibaba Group HLDG LTD(BABA)Sponsored ADS | Q2 2017 | $1.2bnQ1 2025 | $192m | |
| Spdr S&P 500 Etf Trust(SPY) | Q1 2016 | $5.3bnQ2 2019 | Soldlast listed Q2 2019 | |
| SPDR Ser S&P 500 ETF(SPYX) | Q1 2025 | $2.5bnQ1 2025 | Soldlast listed Q1 2025 | |
| Invesco QQQ Trust(QQQ) | Q2 2019 | $1.5bnQ2 2019 | Soldlast listed Q2 2019 | |
| Powershares QQQ TrustUnit Series 1 | Q2 2017 | $903mQ4 2017 | Soldlast listed Q1 2018 | |
| Allergan PLC | Q1 2016 | $895mQ4 2016 | Soldlast listed Q1 2020 | |
| Apple Inc(AAPL) | Q3 2016 | $776mQ4 2017 | Soldlast listed Q2 2023 | |
| Unitedhealth Group Inc(UNH) | Q1 2017 | $764mQ2 2025 | Soldlast listed Q1 2026 | |
| Pg&e Corp(PCG) | Q4 2017 | $758mQ3 2020 | Soldlast listed Q2 2022 |
Quarter by quarter
Q2 2017: $6.7bn across 58 positions
Against Q1 2017: 24 new, 11 added to, 20 trimmed, 19 sold out, across all 58 positions.
Turnover about 34% of the book, estimated from share changes at quarter-end prices.
Largest additions
- Micron Technology Inc (MU)+$192m
- Alphabet Inc (GOOG)+$138m
- Western Digital Corp (WDC)+$120m
- Facebook Inc (META)+$85m
- Apple Inc (AAPL)+$47m
- United Rentals Inc (URI)+$42m
- Thermo Fisher Scientific Inc (TMO)+$41m
- Unitedhealth Group Inc (UNH)+$37m
Largest reductions
- Southwest Airls Co (LUV)-$127m
- General MTRS Co (GM)-$117m
- Allergan PLC-$92m
- Kinder Morgan Inc Del (KMI)-$39m
- Williams Partners L P New-$39m
- Hca Holdings Inc (HCA)-$29m
- Nucor Corp (NUE)-$24m
- Boston Scientific Corp (BSX)-$20m
Opened
- Alibaba Group HLDG LTD (BABA)$520m
- Energy Transfer Partners LP$303m
- Altaba Inc$279m
- Powershares QQQ Trust$250m
- iShares Nasdq Biotec ETF (IBB)$73m
Sold out
- Energy Transfer Prtnrs L Pwas $437m
- Spdr S&P 500 Etf Trust (SPY)was $354m
- Regions Finl Corp New (RF)was $128m
- Pfizer Inc (PFE)was $103m
- Yahoo Incwas $102m
- Mylan N Vwas $74m
- Teva Pharmaceutical Inds LTD (TEVA)was $70m
- Symantec Corpwas $48m
Largest positions, Q2 2017
The largest 25 of 58 reported positions.
| Position | Value | Weight | On the quarter |
|---|---|---|---|
| Allergan PLC | $610m | 9.0% | Trimmed |
| Alphabet Inc (GOOG) | $532m | 7.9% | Added |
| Alibaba Group HLDG LTD (BABA) | $520m | 7.7% | New |
| Micron Technology Inc (MU) | $385m | 5.7% | Added |
| Williams Partners L P New | $368m | 5.5% | Trimmed |
| Facebook Inc (META) | $356m | 5.3% | Added |
| Energy Transfer Partners LP | $303m | 4.5% | New |
| Altaba Inc | $279m | 4.1% | New |
| Powershares QQQ Trust | $250m | 3.7% | New |
| Western Digital Corp (WDC) | $228m | 3.4% | Added |
| PNC Finl SVCS Group Inc (PNC) | $223m | 3.3% | Trimmed |
| Bank Amer Corp (BAC) | $213m | 3.2% | Held |
| Owens Corning New (OC) | $167m | 2.5% | Trimmed |
| Allstate Corp (ALL) | $150m | 2.2% | Trimmed |
| Huntsman Corp (HUN) | $138m | 2.1% | Trimmed |
| United Rentals Inc (URI) | $130m | 1.9% | Added |
| Mohawk Inds Inc (MHK) | $112m | 1.7% | Trimmed |
| Terraform PWR Inc | $105m | 1.6% | Held |
| Atlantica Yield PLC | $100m | 1.5% | Trimmed |
| Apple Inc (AAPL) | $90m | 1.3% | Added |
| Unitedhealth Group Inc (UNH) | $87m | 1.3% | Added |
| Centene Corp Del (CNC) | $77m | 1.1% | Trimmed |
| Kinder Morgan Inc Del (KMI) | $76m | 1.1% | Trimmed |
| Whirlpool Corp (WHR) | $75m | 1.1% | Trimmed |
| iShares Nasdq Biotec ETF (IBB) | $73m | 1.1% | New |
The books most like this one
Among the managers whose filings are on file, at Q2 2026. Overlap is the share of the two books that is the same: for every stock both list, the smaller of its two weights, added up. Two books can overlap because both own the largest companies; it says nothing about whether the managers agree.
| Manager | Overlap | Stocks in both | Overlap over time | |
|---|---|---|---|---|
| Altimeter Capital Management LP | 34% | 10 | Compare | |
| Coatue Management LLC | 33% | 12 | Compare | |
| Tiger Global Management LLC | 33% | 9 | Compare | |
| Baupost Group LLC | 24% | 2 | Compare | |
| Polen Capital Management LLC | 23% | 11 | Compare | |
| Egerton Capital UK LLP | 23% | 5 | Compare | |
| Pershing Square Capital Management LP | 23% | 3 | Compare | |
| Maverick Capital Ltd | 21% | 11 | Compare |
The filings behind it
Every quarter above is one 13F holdings report, with any amendment the filer made to it applied in the order it was filed. Where the reporting entity changed, each quarter keeps the filer that actually reported it.
| Quarter | Filer | Book | Amended | Filing |
|---|---|---|---|---|
| Q2 2026 | Appaloosa LP | $7.7bn | 13F-HR | |
| Q1 2026 | Appaloosa LP | $5.9bn | 13F-HR | |
| Q4 2025 | Appaloosa LP | $6.9bn | 13F-HR | |
| Q3 2025 | Appaloosa LP | $7.4bn | 13F-HR | |
| Q2 2025 | Appaloosa LP | $6.4bn | 13F-HR | |
| Q1 2025 | Appaloosa LP | $8.4bn | 13F-HR | |
| Q4 2024 | Appaloosa LP | $6.5bn | 13F-HR | |
| Q3 2024 | Appaloosa LP | $6.7bn | 13F-HR | |
| Q2 2024 | Appaloosa LP | $6.2bn | 13F-HR | |
| Q1 2024 | Appaloosa LP | $6.8bn | 13F-HR | |
| Q4 2023 | Appaloosa LP | $5.8bn | 13F-HR | |
| Q3 2023 | Appaloosa LP | $5.1bn | 13F-HR | |
| Q2 2023 | Appaloosa LP | $5.4bn | 13F-HR | |
| Q1 2023 | Appaloosa LP | $1.9bn | 13F-HR | |
| Q4 2022 | Appaloosa LP | $1.3bn | 13F-HR | |
| Q3 2022 | Appaloosa LP | $1.4bn | 13F-HR | |
| Q2 2022 | Appaloosa LP | $1.6bn | 13F-HR | |
| Q1 2022 | Appaloosa LP | $2.5bn | 13F-HR | |
| Q4 2021 | Appaloosa LP | $3.9bn | 13F-HR | |
| Q3 2021 | Appaloosa LP | $4.2bn | 13F-HR | |
| Q2 2021 | Appaloosa LP | $4.8bn | 13F-HR | |
| Q1 2021 | Appaloosa LP | $7.0bn | 13F-HR | |
| Q4 2020 | Appaloosa LP | $6.7bn | 13F-HR | |
| Q3 2020 | Appaloosa LP | $5.7bn | 13F-HR | |
| Q2 2020 | Appaloosa LP | $5.8bn | 13F-HR | |
| Q1 2020 | Appaloosa LP | $3.3bn | 13F-HR | |
| Q4 2019 | Appaloosa LP | $4.0bn | 13F-HR | |
| Q3 2019 | Appaloosa LP | $3.4bn | 13F-HR | |
| Q2 2019 | Appaloosa LP | $9.3bn | 13F-HR | |
| Q1 2019 | Appaloosa LP | $3.5bn | 13F-HR | |
| Q4 2018 | Appaloosa LP | $2.0bn | 13F-HR | |
| Q3 2018 | Appaloosa LP | $5.7bn | 13F-HR | |
| Q2 2018 | Appaloosa LP | $8.8bn | 13F-HR | |
| Q1 2018 | Appaloosa LP | $9.7bn | 13F-HR | |
| Q4 2017 | Appaloosa LP | $10.7bn | 13F-HR | |
| Q3 2017 | Appaloosa LP | $7.1bn | 13F-HR | |
| Q2 2017 | Appaloosa LP | $6.7bn | 13F-HR | |
| Q1 2017 | Appaloosa LP | $6.1bn | 13F-HR | |
| Q4 2016 | Appaloosa LP | $5.6bn | 13F-HR | |
| Q3 2016 | Appaloosa LP | $4.4bn | 13F-HR | |
| Q2 2016 | Appaloosa LP | $3.8bn | 13F-HR | |
| Q1 2016 | Appaloosa LP | $5.7bn | 13F-HR |
Reading this record
A 13F lists US-listed long equity and options at the quarter end, filed up to 45 days later. It shows what was held, not when it was bought or at what price, and nothing short. Where a quarter lists only the largest positions, a name missing from it may still be held below that range; the counts of what was opened and sold always cover the whole filing.
Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More